Company NameGlaxosmithkline Investment Holdings Limited
Company StatusDissolved
Company Number07089743
CategoryPrivate Limited Company
Incorporation Date27 November 2009(12 years, 7 months ago)
Dissolution Date18 April 2022 (2 months, 1 week ago)

Business Activity

Section MProfessional, scientific and technical activities
SIC 7415Holding Companies including Head Offices
SIC 70100Activities of head offices

Directors

Director NameMr John Michael Sadler
Date of BirthMarch 1956 (Born 66 years ago)
NationalityBritish
StatusClosed
Appointed07 August 2020(10 years, 8 months after company formation)
Appointment Duration1 year, 8 months (closed 18 April 2022)
RoleCompany Director
Country of ResidenceEngland
Correspondence Address55 Baker Street
London
W1U 7EU
Director NameMrs Sarah Ghinn
Date of BirthAugust 1963 (Born 58 years ago)
NationalityBritish
StatusClosed
Appointed07 August 2020(10 years, 8 months after company formation)
Appointment Duration1 year, 8 months (closed 18 April 2022)
RoleCompany Director
Country of ResidenceEngland
Correspondence Address55 Baker Street
London
W1U 7EU
Secretary NameEdinburgh Pharmaceutical Industries Limited (Corporation)
StatusClosed
Appointed27 November 2009(same day as company formation)
Correspondence AddressShewalton Road Shewalton Road
Irvine
Ayrshire
KA11 5AP
Scotland
Director NameMr Paul Frederick Blackburn
Date of BirthOctober 1954 (Born 67 years ago)
NationalityBritish
StatusResigned
Appointed27 November 2009(same day as company formation)
RoleAccountant
Country of ResidenceUnited Kingdom
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMr Adam Walker
Date of BirthNovember 1967 (Born 54 years ago)
NationalityBritish
StatusResigned
Appointed30 April 2015(5 years, 5 months after company formation)
Appointment Duration5 years, 3 months (resigned 07 August 2020)
RoleCompany Director
Country of ResidenceEngland
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameEdinburgh Pharmaceutical Industries Limited (Corporation)
StatusResigned
Appointed27 November 2009(same day as company formation)
Correspondence AddressShewalton Road Shewalton Road
Irvine
Ayrshire
KA11 5AP
Scotland
Director NameGlaxo Group Limited (Corporation)
StatusResigned
Appointed27 November 2009(same day as company formation)
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS

Contact

Websitegsk.com
Telephone020 80475000
Telephone regionLondon

Location

Registered AddressBdo Llp
55 Baker Street
London
W1U 7EU
RegionLondon
ConstituencyCities of London and Westminster
CountyGreater London
WardMarylebone High Street
Built Up AreaGreater London
Address Matches9 other UK companies use this postal address

Shareholders

2.5b at £1Setfirst LTD
100.00%
Ordinary

Financials

Year2014
Net Worth£2,147,483,647
Current Liabilities£10,156,000

Accounts

Latest Accounts31 December 2019 (2 years, 6 months ago)
Accounts CategoryTotal Exemption Full
Accounts Year End31 December

Filing History

18 January 2022Return of final meeting in a members' voluntary winding up (24 pages)
20 October 2021Liquidators' statement of receipts and payments to 7 October 2021 (15 pages)
5 December 2020Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 55 Baker Street London W1U 7EU on 5 December 2020 (2 pages)
29 October 2020Resolutions
  • LRESSP ‐ Special resolution to wind up on 2020-10-08
(1 page)
28 October 2020Appointment of a voluntary liquidator (3 pages)
28 October 2020Declaration of solvency (5 pages)
7 September 2020Total exemption full accounts made up to 31 December 2019 (15 pages)
14 August 2020Termination of appointment of Glaxo Group Limited as a director on 7 August 2020 (1 page)
14 August 2020Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 7 August 2020 (1 page)
14 August 2020Termination of appointment of Adam Walker as a director on 7 August 2020 (1 page)
14 August 2020Appointment of Sarah Ghinn as a director on 7 August 2020 (2 pages)
14 August 2020Appointment of Mr John Sadler as a director on 7 August 2020 (2 pages)
1 June 2020Consolidated accounts of parent company for subsidiary company period ending 31/12/19 (316 pages)
20 February 2020Audit exemption statement of guarantee by parent company for period ending 31/12/19 (3 pages)
20 February 2020Notice of agreement to exemption from audit of accounts for period ending 31/12/19 (1 page)
16 December 2019Confirmation statement made on 27 November 2019 with updates (4 pages)
11 September 2019Full accounts made up to 31 December 2018 (15 pages)
8 January 2019Confirmation statement made on 27 November 2018 with updates (4 pages)
12 July 2018Full accounts made up to 31 December 2017 (16 pages)
30 November 2017Confirmation statement made on 27 November 2017 with updates (4 pages)
30 November 2017Confirmation statement made on 27 November 2017 with updates (4 pages)
14 August 2017Full accounts made up to 31 December 2016 (14 pages)
14 August 2017Full accounts made up to 31 December 2016 (14 pages)
28 November 2016Confirmation statement made on 27 November 2016 with updates (5 pages)
28 November 2016Confirmation statement made on 27 November 2016 with updates (5 pages)
17 June 2016Full accounts made up to 31 December 2015 (14 pages)
17 June 2016Full accounts made up to 31 December 2015 (14 pages)
1 March 2016Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
1 March 2016Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
14 December 2015Annual return made up to 27 November 2015 with a full list of shareholders
Statement of capital on 2015-12-14
  • GBP 2,547,000,100
(6 pages)
14 December 2015Annual return made up to 27 November 2015 with a full list of shareholders
Statement of capital on 2015-12-14
  • GBP 2,547,000,100
(6 pages)
1 May 2015Appointment of Mr Adam Walker as a director on 30 April 2015 (2 pages)
1 May 2015Appointment of Mr Adam Walker as a director on 30 April 2015 (2 pages)
15 April 2015Full accounts made up to 31 December 2014 (11 pages)
15 April 2015Full accounts made up to 31 December 2014 (11 pages)
10 December 2014Annual return made up to 27 November 2014 with a full list of shareholders
Statement of capital on 2014-12-10
  • GBP 2,547,000,100
(5 pages)
10 December 2014Annual return made up to 27 November 2014 with a full list of shareholders
Statement of capital on 2014-12-10
  • GBP 2,547,000,100
(5 pages)
9 December 2014Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
9 December 2014Director's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
9 December 2014Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
9 December 2014Director's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
10 April 2014Full accounts made up to 31 December 2013 (11 pages)
10 April 2014Full accounts made up to 31 December 2013 (11 pages)
13 December 2013Annual return made up to 27 November 2013 with a full list of shareholders
Statement of capital on 2013-12-13
  • GBP 2,547,000,100
(5 pages)
13 December 2013Annual return made up to 27 November 2013 with a full list of shareholders
Statement of capital on 2013-12-13
  • GBP 2,547,000,100
(5 pages)
22 April 2013Full accounts made up to 31 December 2012 (10 pages)
22 April 2013Full accounts made up to 31 December 2012 (10 pages)
12 December 2012Annual return made up to 27 November 2012 with a full list of shareholders (5 pages)
12 December 2012Annual return made up to 27 November 2012 with a full list of shareholders (5 pages)
29 August 2012Full accounts made up to 31 December 2011 (10 pages)
29 August 2012Full accounts made up to 31 December 2011 (10 pages)
20 December 2011Annual return made up to 27 November 2011 with a full list of shareholders (5 pages)
20 December 2011Annual return made up to 27 November 2011 with a full list of shareholders (5 pages)
1 December 2011Statement of capital on 1 December 2011
  • GBP 254.70
(4 pages)
1 December 2011Statement by directors (2 pages)
1 December 2011Solvency statement dated 01/12/11 (2 pages)
1 December 2011Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
(1 page)
1 December 2011Statement of capital on 1 December 2011
  • GBP 254.70
(4 pages)
1 December 2011Statement of capital on 1 December 2011
  • GBP 254.70
(4 pages)
1 December 2011Statement by directors (2 pages)
1 December 2011Solvency statement dated 01/12/11 (2 pages)
1 December 2011Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
(1 page)
14 April 2011Full accounts made up to 31 December 2010 (10 pages)
14 April 2011Full accounts made up to 31 December 2010 (10 pages)
20 December 2010Annual return made up to 27 November 2010 with a full list of shareholders (15 pages)
20 December 2010Annual return made up to 27 November 2010 with a full list of shareholders (15 pages)
21 January 2010Statement of capital following an allotment of shares on 18 January 2010
  • GBP 2,547,000,100
(4 pages)
21 January 2010Current accounting period extended from 30 November 2010 to 31 December 2010 (2 pages)
21 January 2010Statement of capital following an allotment of shares on 18 January 2010
  • GBP 2,547,000,100
(4 pages)
21 January 2010Current accounting period extended from 30 November 2010 to 31 December 2010 (2 pages)
27 November 2009Incorporation (50 pages)
27 November 2009Incorporation (50 pages)